Pharmafile Logo
Pharmafocus logo
Advanced Search
mosquito-1016254_1280

First new treatment for reccurent malaria approved in over 60 years

July 23, 2018
Manufacturing and Production FDA, GSK, approval, malaria, p.vivax

The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …

News
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …

Feature

FDA approves Agios’ oral leukaemia treatment Tibsovo

July 23, 2018
Sales and Marketing FDA, agios, approval, pharmaceuticals, tibsovo

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …

News
allergan

US court overturns Allergan’s controversial attempts to avoid Restasis patent review

July 23, 2018
Sales and Marketing Allergan, Mylan, Restasis, US, dry eye, pharma

The US Court of Appeals for the Federal Circuit has seen fit to authorise a US Patent and Trademark Office …

News
roche_dark_0

Roche join Pfizer and others in price freeze while critics pose questions

July 23, 2018
Sales and Marketing Donald Trump, Roche, generics, price freezes

Swiss multinational Roche has joined Pfizer and others in halting price hikes. However critics have condemned the move as observers …

News
fda2outsideweb

FDA approves Pfizer biosimilar version of Amgen’s Neupogen

July 23, 2018
Sales and Marketing Amgen, FDA, Neupogen, Nivestym, Pfizer, pharma

The FDA has announced its decision to approve Pfizer’s Nivestym, the firm’s biosimilar version of Amgen’s Neupogen (filgrastim), for use …

News
li_keqiang_chinese_and_foreign_press_conference

Chinese premier slams drug maker after vaccine scandal

July 23, 2018
Sales and Marketing CCP, China, biotech, scandal, vaccines

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 20, 2018
Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10

As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …

News
ki67-tubulin-2

Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics

July 20, 2018
Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn

The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …

News
16792957331_d9572dbdf4_z

FDA explores import strategy in effort to reduce price of drugs

July 20, 2018
Medical Communications Drug pricing, Trump, borders, import, the donald

The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …

News
merckwindow_web

Merck joins Pizer and Novartis in reducing drug prices

July 20, 2018
Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes

Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …

News
donald_trump_29496131773

Donald Trump thanks Novartis for halting price hikes

July 20, 2018
Medical Communications Novartis, Pfizer, Trump, Twitter, price hikes

Donald Trump has thanked Swiss multinational Novartis for halting price hikes on prescription drugs in the United States. The US …

News

Novartis buys eczema drug in €95m deal

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …

News

PhRMA take on PBM’s in response to Trump drug price plan

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …

News
28246711066_52e38bc591_z

MPs vote to stay in EMA after Brexit

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …

News
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …

News
janssen_latest_logo_on_sign

Janssen’s Symtuza scores approval with the FDA in HIV-1

July 18, 2018
Sales and Marketing HIV, Janssen, Symtuza, pharma

Janssen has announced that Symtuza (D/C/F/TAF) has received approval from the FDA in the treatment of human immunodeficiency virus type …

News
astrazeneca_plaque

AstraZeneca increases drug stockpile in preparation for no-deal Brexit

July 18, 2018
Research and Development AstraZeneca, brexit, no-deal, pharma, stockpiling

The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the …

News
shutterstock_138095450

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …

News
administration_building_mclean_hospital_belmont_ma

Researchers develop algorithm able to identify antidepressant suitability

July 18, 2018
Research and Development McLean, algorithm, antidepressants, research

A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026